Diagnostic Lab Testing Transparency Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Diagnostic Lab Testing Transparency Act (H.R. 3248) was a bill introduced in the 118th Congress aimed at increasing transparency in diagnostic laboratory testing. Although the official summary and full text are not available, the bill's title and policy area indicate its focus on health-related diagnostic labs. The latest action was referral to the Subcommittee on Health on December 17, 2024. The bill ultimately failed or expired without further legislative progress.
H.R. 3248 sought to enhance transparency in diagnostic lab testing but did not advance beyond early committee consideration and expired without enactment.
- The bill is focused on transparency in diagnostic laboratory testing within the health policy area.
- It was introduced in the House during the 118th Congress but did not progress beyond referral to a subcommittee.
- No official summary or full text is publicly available, limiting detailed analysis of provisions.
['Patients seeking diagnostic lab tests who may gain clearer information about testing processes and costs', 'Healthcare providers who rely on diagnostic lab results', 'Diagnostic laboratories potentially affected by transparency requirements', 'Health policy regulators and oversight bodies']
['Lack of publicly available full text and summary limits understanding of implementation mechanisms and enforcement', 'Potential administrative and compliance costs for diagnostic laboratories', 'Unclear oversight and enforcement authority due to missing legislative details', 'Possible tradeoffs between transparency and proprietary business information for labs']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not advance further and expired, indicating limited legislative momentum. The focus on diagnostic lab transparency aligns with ongoing health policy discussions about healthcare cost transparency and quality assurance.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Improved transparency in diagnostic lab testing could lead to increased patient awareness and potentially influence healthcare decision-making.', 'Diagnostic laboratories may need to adjust operational practices to comply with transparency requirements, affecting business processes.', 'Healthcare providers might experience changes in how lab testing information is communicated and documented.']
The absence of an official summary and full bill text presents a significant transparency gap, hindering public and stakeholder understanding of the bill's specific provisions and potential impacts. The bill's failure to progress beyond subcommittee referral further limits oversight opportunities and public discourse.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.